BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers

Drugs
Jaquelyn N SanchezMark S Cohen

Abstract

The mitogen activated protein kinase/extracellular signal-related kinase (MAPK/ERK) signaling pathway serves an integral role in growth, proliferation, differentiation, migration, and survival of all mammalian cells. Aberrant signaling of this pathway is often observed in several types of hematologic and solid malignancies. The most frequent insult to this signaling cascade, leading to its constitutive activation, is to the serine/threonine kinase rapidly accelerating fibrosarcoma (RAF). Considering this, the development and approval of various small-molecule inhibitors targeting the MAPK/ERK pathway has become a mainstay of treatment as either mono- or combination therapy in these cancers. Although effective initially, a major clinical barrier with these inhibitors is the relapse of patients due to drug resistance. Knowledge of the mechanisms of resistance to these drugs is still premature, highlighting the need for a more in-depth understanding of how patients become insensitive to these pharmacologic interventions. Herein, we will succinctly summarize the milestones in the approval of select MAPK/ERK pathway inhibitors, their use in patients, and major modes of resistance.

References

Mar 15, 1997·Genes & Development·S G KennedyN Hay
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
Jun 6, 2003·Oncogene·Heng WuFrank G Haluska
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
May 15, 2007·Oncogene·A S DhillonW Kolch
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Sep 16, 2008·Molecular Cancer Therapeutics·Keiran S M SmalleyKatherine L Nathanson
Jul 3, 2009·The New England Journal of Medicine·Jolien TolCornelis J A Punt
Nov 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Caroline M EmeryLevi A Garraway
Feb 25, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Udai BanerjiCarla M L van Herpen
Mar 17, 2010·Journal of the Chinese Medical Association : JCMA·Kam-Tsun Tang, Chen-Hsen Lee
Aug 31, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·John D HainsworthValentina Tzekova
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
Nov 26, 2010·Nature·Cory M JohannessenLevi A Garraway
Feb 25, 2011·The New England Journal of Medicine·David B Solit, Neal Rosen
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jun 15, 2011·The New England Journal of Medicine·Enrico TiacciBrunangelo Falini
Nov 10, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick A OberholzerLevi A Garraway
Nov 23, 2011·The Journal of Clinical Investigation·Debyani ChakravartyJames A Fagin
Jan 14, 2012·Expert Opinion on Therapeutic Targets·Parthasarathy SeshacharyuluSurinder K Batra
Jan 20, 2012·The New England Journal of Medicine·Fei SuRichard Marais
May 5, 2012·Journal of Translational Medicine·Paolo A AsciertoNicola Mozzillo
May 17, 2012·Cancer Research·Ian A PriorCarla Mattos
Jun 6, 2012·The New England Journal of Medicine·Keith T FlahertyUNKNOWN METRIC Study Group
Aug 28, 2012·Current Pharmaceutical Design·Yoshihiko MiyataLen Neckers
Dec 19, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin B KimKarl D Lewis
Dec 20, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Muling MaoScott Kopetz
Feb 13, 2013·Clinical and Experimental Dermatology·G W M Millington
Feb 15, 2013·The New England Journal of Medicine·Alan L HoJames A Fagin
Apr 5, 2013·The New England Journal of Medicine·Antoni RibasJedd Wolchok
May 18, 2013·Cancer Cell·Matthew HolderfieldTobi E Nagel

❮ Previous
Next ❯

Citations

Feb 6, 2020·International Journal of Molecular Sciences·Francesca Varrone, Emilia Caputo
Nov 26, 2019·Oncotarget·Laura CroceMario Rotondi
Jul 2, 2020·International Journal of Molecular Sciences·Anna M CzarneckaPiotr Rutkowski
Feb 28, 2020·Experimental and Therapeutic Medicine·Yan-Jun GuoLing-Ling Hu
Feb 6, 2020·Cancer Cell International·Giuseppe Nicolò FanelliMatteo Fassan
Dec 29, 2019·Cancers·Noemi García-RomeroAngel Ayuso-Sacido
Mar 21, 2020·Current Treatment Options in Oncology·Subashini Sharon GnanendranAndrew Charles Miller
Jun 20, 2020·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Ciaran Scott HillKristian Aquilina
Feb 9, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Mengnan ZengXiaoke Zheng
Oct 17, 2019·Nanomaterials·Jacinta Oliveira PinhoMaria Manuela Gaspar
Feb 13, 2020·International Journal of Molecular Sciences·Shannon LeeWalter Kolch
Dec 18, 2020·Frontiers in Oncology·Wen-Long GuanFeng-Hua Wang
May 12, 2020·Bioorganic & Medicinal Chemistry Letters·Ada J Kwong, Karl A Scheidt
Nov 16, 2019·Journal of Medicinal Chemistry·Jieli WeiJian Jin
Dec 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Miguel Angel Galván MoralesLuis M Teran
Oct 24, 2020·Cancers·Lukasz KurykMariangela Garofalo
Jan 7, 2021·Journal of Hematology & Oncology·Jing HanQiming Wang
Mar 7, 2021·Pharmaceuticals·Ottavia BernocchiDaniele Generali
Jul 10, 2021·Journal of Hematology & Oncology·Umair MajeedYanyan Lou
Jul 24, 2020·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Jyoti SinghAbha Meena
Jun 24, 2021·Expert Opinion on Drug Discovery·Monica Chanda, Mark S Cohen
Sep 1, 2021·Molecular Cancer Research : MCR·Michelle Yee Mun TeoLionel Lian Aun In

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

© 2022 Meta ULC. All rights reserved